Tyrosine kinase - Role and significance in Cancer
- PMID: 15912202
- PMCID: PMC1074718
- DOI: 10.7150/ijms.1.101
Tyrosine kinase - Role and significance in Cancer
Abstract
Tyrosine kinases are important mediators of the signaling cascade, determining key roles in diverse biological processes like growth, differentiation, metabolism and apoptosis in response to external and internal stimuli. Recent advances have implicated the role of tyrosine kinases in the pathophysiology of cancer. Though their activity is tightly regulated in normal cells, they may acquire transforming functions due to mutation(s), overexpression and autocrine paracrine stimulation, leading to malignancy. Constitutive oncogenic activation in cancer cells can be blocked by selective tyrosine kinase inhibitors and thus considered as a promising approach for innovative genome based therapeutics. The modes of oncogenic activation and the different approaches for tyrosine kinase inhibition, like small molecule inhibitors, monoclonal antibodies, heat shock proteins, immunoconjugates, antisense and peptide drugs are reviewed in light of the important molecules. As angiogenesis is a major event in cancer growth and proliferation, tyrosine kinase inhibitors as a target for anti-angiogenesis can be aptly applied as a new mode of cancer therapy. The review concludes with a discussion on the application of modern techniques and knowledge of the kinome as means to gear up the tyrosine kinase drug discovery process.
Conflict of interest statement
Figures
Similar articles
-
Tyrosine kinase receptors as attractive targets of cancer therapy.Crit Rev Oncol Hematol. 2004 Apr;50(1):23-38. doi: 10.1016/j.critrevonc.2003.08.004. Crit Rev Oncol Hematol. 2004. PMID: 15094157 Review.
-
Etiologic Role of Kinases in the Progression of Human Cancers and Its Targeting Strategies.Indian J Surg Oncol. 2021 Apr;12(Suppl 1):34-45. doi: 10.1007/s13193-019-00972-z. Epub 2019 Aug 19. Indian J Surg Oncol. 2021. PMID: 33994726 Free PMC article.
-
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy.Clin Cancer Res. 2004 Jan 15;10(2):784-93. doi: 10.1158/1078-0432.ccr-1100-03. Clin Cancer Res. 2004. PMID: 14760102
-
Targeting Small Molecule Tyrosine Kinases by Polyphenols: New Move Towards Anti-tumor Drug Discovery.Curr Drug Discov Technol. 2020;17(5):585-615. doi: 10.2174/1570163816666190808120843. Curr Drug Discov Technol. 2020. PMID: 31393251 Review.
-
Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer.J Biol Chem. 2000 Oct 27;275(43):33937-44. doi: 10.1074/jbc.M000743200. J Biol Chem. 2000. PMID: 10938266
Cited by
-
Recent developments in receptor tyrosine kinases targeted anticancer therapy.Vet World. 2016 Jan;9(1):80-90. doi: 10.14202/vetworld.2016.80-90. Epub 2016 Jan 29. Vet World. 2016. PMID: 27051190 Free PMC article. Review.
-
Electrochemical and theoretical studies of the interaction between anticancer drug ponatinib and dsDNA.Sci Rep. 2024 Jan 27;14(1):2278. doi: 10.1038/s41598-024-52609-z. Sci Rep. 2024. PMID: 38280929 Free PMC article.
-
Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis.BMC Cancer. 2015 Mar 7;15:104. doi: 10.1186/s12885-015-1130-3. BMC Cancer. 2015. PMID: 25880726 Free PMC article.
-
Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer.Cancers (Basel). 2019 Apr 29;11(5):597. doi: 10.3390/cancers11050597. Cancers (Basel). 2019. PMID: 31035440 Free PMC article. Review.
-
Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs.Pharmaceuticals (Basel). 2023 Oct 9;16(10):1435. doi: 10.3390/ph16101435. Pharmaceuticals (Basel). 2023. PMID: 37895906 Free PMC article.
References
-
- Hunter T. Signaling-2000 and Beyond. Cell. 2000;100:113–127. - PubMed
-
- Schlessinger J. Cell Signaling by receptor tyrosine kinases. Cell. 2000;103:211–225. - PubMed
-
- Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001;411:355–365. - PubMed
-
- Hunter T, Cooper JA. Protein-tyrosine kinases. Annu Rev Biochem. 1985;54:897–930. - PubMed
-
- Carpenter G, King LJr, Cohen S. Epidermal growth factor stimulates phosphorylation in membrane preperations in vitro. Nature. 1978;276:409–410. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials